3Schubbert S,Shannon K,Bollag G.Hyperactive Ras in developmental disorders and cancer[J].Nat Rev Cancer,2007,7(4):295-308.
4Rouleau E Spyratos F,Dieumegard B,et al.Kras mutation status in colorectal cancer to predict response to EGFR targeted therapies:the need for a more precise definition[J].Br JCancer,2008,99(12):2100.
5Zuo Y,Cao J,Zhu G,et al.Mutations in epidermal growth factor receptor and K-RAS in Chinese patients with colorectal cancer[J].BMC Med Genet,2010,11(16):450-451.
6Chang YS,Yeh KT,Chang TJ,et al.Fast simultaneous detection of K-ras mutations in colorectal cancer[J].BMC Cancer,2009,9(11):179.
9Ikenaga M,Takano Y,Ohtani Y,et al.Low levels of apoptosis and proliferative activity in colorectal villous tumors:comparation with tubular tumors[J].Pathol Int,1998,48(6):453-459.
9Pascale F,Eva NE,Sall JL.Control of growth and differentiation by drosophila RasGAP,a homolog of p120 Ras-GTPase-Activating protein.Mol Cell Biol,1999,19:1928-1937.
10Schaich M,Illmer T.Mdr1 gene expression and mutations in Ras proto-oncogene in acute myeloid leukemia.Leuk Lymphoma,2002,43:1345-1354.
